Recursion Pharmaceuticals Inc RXRX

Healthcare Biotechnology

Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate in silico hypotheses into validated insights and novel chemistry. Its clinical programs include REC-994, REC-2282, REC-4881 and REC-3964. REC-994 is an orally bioavailable, superoxide scavenger small molecule being development for the treatment of symptomatic cerebral cavernous malformation (CCM). REC-2282 for the potential treatment of neurofibromatosis type 2. REC-3964 for the prevention of recurrent Clostridioides difficile infection.

NDAQ:RXRX - Post by User

Recursion Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by whytestockson Jun 07, 2024 10:00pm

109 Views

Post# 36078854

Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but On

JUST IN: $RXRX Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim2024-06-07 09:00:00 ET Investing in growth stocks can lead to significant returns for investors in the long run. But oftentimes, the best returns come from smaller stocks, which have modest market values. These stocks can be risky options, but due to their low valuations, they tend to have ...RXRX - Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec